David Boulate1, Olaf Mercier2, Sacha Mussot1, Dominique Fabre1, François Stephan3, François Haddad4, Xavier Jaïs5, Philippe Dartevelle1, Elie Fadel1. 1. Department of Thoracic, Vascular, and Heart-Lung Transplantation, Marie Lannelongue Hospital, Le Plessis-Robinson, Paris South University, France. 2. Department of Thoracic, Vascular, and Heart-Lung Transplantation, Marie Lannelongue Hospital, Le Plessis-Robinson, Paris South University, France. Electronic address: o.mercier@ccml.fr. 3. Adult Intensive Care Unit, Marie Lannelongue Hospital, Le Plessis-Robinson, Paris South University, France. 4. Cardiovascular Medicine, Stanford Hospital, Stanford University, California. 5. Department of Pulmonology and Respiratory Intensive Care, Bicêtre Hospital, Le Kremlin-Bicêtre, Paris South University, France.
Abstract
BACKGROUND: Extracorporeal life support (ECLS) can be used to sustain patients having cardiorespiratory failure after pulmonary endarterectomy (PEA). We aimed to assess outcomes and to identify factors associated with short-term survival among patients who required ECLS after PEA. METHODS: We reviewed the charts of consecutive patients who required ECLS after PEA between 2005 and 2013 at our institution. Patients with failed PEA were scheduled for heart-lung transplantation, and patients with potentially reversible hemodynamic or respiratory failure were given appropriate supportive care until recovery. RESULTS: Of the 829 patients who underwent PEA, 31 (3.7%) required postoperative ECLS. Of these, 23 continued to receive support, and 8 were listed for heart-lung transplantation during ECLS. Overall inhospital survival was 48.4% (15 of 31). Of patients listed for transplantation, 2 died while on support; 4 of the 6 patients undergoing transplantation lived to hospital discharge. Of the 23 supportive care patients, 11 (47.8%) were alive at hospital discharge. The factors associated with survival were younger age (p = 0.02), larger post-PEA decrease in mean pulmonary artery pressure (p = 0.020), lower post-PEA total pulmonary resistance (p = 0.008), and pure respiratory failure related to reperfusion edema or airway bleeding (p = 0.003). CONCLUSIONS: Extracorporeal life support may be useful to support patients with complications after PEA either to recovery or to salvage transplantation.
BACKGROUND: Extracorporeal life support (ECLS) can be used to sustain patients having cardiorespiratory failure after pulmonary endarterectomy (PEA). We aimed to assess outcomes and to identify factors associated with short-term survival among patients who required ECLS after PEA. METHODS: We reviewed the charts of consecutive patients who required ECLS after PEA between 2005 and 2013 at our institution. Patients with failed PEA were scheduled for heart-lung transplantation, and patients with potentially reversible hemodynamic or respiratory failure were given appropriate supportive care until recovery. RESULTS: Of the 829 patients who underwent PEA, 31 (3.7%) required postoperative ECLS. Of these, 23 continued to receive support, and 8 were listed for heart-lung transplantation during ECLS. Overall inhospital survival was 48.4% (15 of 31). Of patients listed for transplantation, 2 died while on support; 4 of the 6 patients undergoing transplantation lived to hospital discharge. Of the 23 supportive care patients, 11 (47.8%) were alive at hospital discharge. The factors associated with survival were younger age (p = 0.02), larger post-PEA decrease in mean pulmonary artery pressure (p = 0.020), lower post-PEA total pulmonary resistance (p = 0.008), and pure respiratory failure related to reperfusion edema or airway bleeding (p = 0.003). CONCLUSIONS: Extracorporeal life support may be useful to support patients with complications after PEA either to recovery or to salvage transplantation.
Authors: Antonio Loforte; Giuseppe Comentale; Gregorio Gliozzi; Giulio Giovanni Cavalli; Davide Pacini; Sofia Martin-Suarez Journal: Ann Cardiothorac Surg Date: 2022-03
Authors: Gil Myeong Seong; Sang-Bum Hong; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Jae Won Lee; Sung-Ho Jung; Duck-Woo Park; Jae Seung Lee Journal: Acute Crit Care Date: 2018-11-07